EGFR gene has the highest amplification frequency (59.4%) of all receptor tyrosine kinases (RTKs) in GBM, and the frequency is up to 95% in the classical subtype, which has the worst prognosis (18, 19). This evidence concerns the gene EGFR and glioblastoma.